• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西运动障碍诊所中的家族性帕金森病和早发性帕金森病:SNCA、PRKN、PINK1和LRRK2突变的表型特征及频率

Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.

作者信息

Camargos Sarah Teixeira, Dornas Leonardo Oliveira, Momeni Parastoo, Lees Andrew, Hardy John, Singleton Andrew, Cardoso Francisco

机构信息

Movement Disorders Group, Neurology Service, Department of Internal Medicine, Federal University of Minas Gerais, Minas Gerais, Brazil.

出版信息

Mov Disord. 2009 Apr 15;24(5):662-6. doi: 10.1002/mds.22365.

DOI:10.1002/mds.22365
PMID:19205068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2850048/
Abstract

The aim of the study was to evaluate the frequency and to perform phenotypic and genotypic characterization of familial Parkinsonism and early onset Parkinson's disease (EOPD) in a Brazilian movement disorder unit. We performed a standardized clinical assessment of patients followed by sequencing of PRKN, PINK1 in EOPD cases and SNCA, LRRK2 in familial Parkinsonism individuals. During the period of study (January through December, 2006), we examined 575 consecutive patients of whom 226 (39.3%) met the diagnosis of Parkinsonism and idiopathic Parkinson's disease (IPD) was diagnosed in 202 of the latter. Of the IPD cases, 45 (22.3%) had EOPD. The age at onset in the EOPD cases (n = 45) was 34.8 +/- 5.4 years (mean +/- standard deviation). The age at onset in the familial late-onset PD patients (n = 8) was 52.3 +/- 12.2 years. In the early onset cases, we identified five known mutations in PRKN, two single heterozygous and three compound heterozygous (P153R, T240M, 255Adel, W54R, V3I); in addition, we identified one novel mutation in PINK1 (homozygous deletion of exon 7). In the familial cases (late onset), 1 patient had a novel LRRK2 variant, Q923H, but no SNCA mutations were identified. We have demonstrated that EOPD accounts for a high frequency of IPD cases in our tertiary referral center. PRKN was the most commonly mutated gene, but we also identified a novel mutation in PINK1 and a novel variant in LRRK2.

摘要

本研究的目的是评估巴西一家运动障碍治疗中心家族性帕金森综合征和早发性帕金森病(EOPD)的发病频率,并进行表型和基因型特征分析。我们对患者进行了标准化临床评估,随后对EOPD病例中的PRKN、PINK1基因以及家族性帕金森综合征患者中的SNCA、LRRK2基因进行测序。在研究期间(2006年1月至12月),我们检查了575例连续患者,其中226例(39.3%)符合帕金森综合征诊断,后者中有202例被诊断为特发性帕金森病(IPD)。在IPD病例中,45例(22.3%)为EOPD。EOPD病例(n = 45)的发病年龄为34.8±5.4岁(平均值±标准差)。家族性晚发性帕金森病患者(n = 8)的发病年龄为52.3±12.2岁。在早发性病例中,我们在PRKN基因中鉴定出5个已知突变,2个单杂合突变和3个复合杂合突变(P153R、T240M、255Adel、W54R、V3I);此外,我们在PINK1基因中鉴定出1个新突变(外显子7纯合缺失)。在家族性病例(晚发性)中,1例患者有LRRK2基因新变异Q923H,但未鉴定出SNCA基因突变。我们已经证明,在我们的三级转诊中心,EOPD在IPD病例中占很高比例。PRKN是最常发生突变的基因,但我们也在PINK1基因中鉴定出1个新突变和LRRK2基因中的1个新变异。

相似文献

1
Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.巴西运动障碍诊所中的家族性帕金森病和早发性帕金森病:SNCA、PRKN、PINK1和LRRK2突变的表型特征及频率
Mov Disord. 2009 Apr 15;24(5):662-6. doi: 10.1002/mds.22365.
2
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.荷兰早发性帕金森病患者的基因型和表型特征。
Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287.
3
Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.对来自葡萄牙的帕金森病患者进行SNCA、PRKN、PINK1和LRRK2基因突变分析。
BMC Neurol. 2008 Jan 22;8:1. doi: 10.1186/1471-2377-8-1.
4
Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.土耳其早发性帕金森病患者中PARKIN、PINK1、DJ1和SNCA基因的突变分析及基因型-表型相关性
Clin Neurol Neurosurg. 2016 Sep;148:147-53. doi: 10.1016/j.clineuro.2016.07.005. Epub 2016 Jul 4.
5
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.LRRK2、SNCA、Parkin、PINK1 和 DJ-1 在赞比亚帕金森病患者中的分析。
Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.
6
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.韩国早发性帕金森病队列中PARK基因的分析。
Neurogenetics. 2008 Oct;9(4):263-9. doi: 10.1007/s10048-008-0138-0. Epub 2008 Aug 15.
7
Analysis of the genetic variability in Parkinson's disease from Southern Spain.西班牙南部帕金森病的遗传变异性分析。
Neurobiol Aging. 2016 Jan;37:210.e1-210.e5. doi: 10.1016/j.neurobiolaging.2015.09.020. Epub 2015 Oct 8.
8
Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.对来自澳大利亚昆士兰州的早发性帕金森病患者的PARK基因进行突变筛查。
Parkinsonism Relat Disord. 2009 Feb;15(2):105-9. doi: 10.1016/j.parkreldis.2007.11.016. Epub 2008 May 19.
9
PINK1 mutations in a Brazilian cohort of early-onset Parkinson's disease patients.巴西早发性帕金森病患者队列中的 PINK1 突变。
Mov Disord. 2009 Aug 15;24(11):1693-6. doi: 10.1002/mds.22685.
10
Clinical genetics of Parkinson's disease and related disorders.帕金森病及相关疾病的临床遗传学
Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5.

引用本文的文献

1
14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state.14-3-3蛋白结合可使帕金森相关激酶LRRK2维持在非活性状态。
Nat Commun. 2025 Aug 5;16(1):7226. doi: 10.1038/s41467-025-62337-1.
2
A Structural Proteomics Exploration of Synphilin-1 and Alpha-Synuclein Interaction in Pathogenesis of Parkinson's Disease.帕金森病发病机制中突触核蛋白-1与α-突触核蛋白相互作用的结构蛋白质组学探索
Biomolecules. 2024 Dec 12;14(12):1588. doi: 10.3390/biom14121588.
3
Mitochondrial DNA Instability Supersedes Parkin Mutations in Driving Mitochondrial Proteomic Alterations and Functional Deficits in Polg Mutator Mice.线粒体 DNA 不稳定性超越 Parkin 突变,驱动 Polg 突变体小鼠的线粒体蛋白质组改变和功能缺陷。
Int J Mol Sci. 2024 Jun 11;25(12):6441. doi: 10.3390/ijms25126441.
4
Towards a Global View of Parkinson's Disease Genetics.迈向帕金森病遗传学的全球视野。
Ann Neurol. 2024 May;95(5):831-842. doi: 10.1002/ana.26905. Epub 2024 Apr 1.
5
A homozygous -associated juvenile Parkinson's disease with pregnancy in China.中国一例与纯合子相关的青少年帕金森病合并妊娠病例
Front Neurol. 2023 Feb 20;14:1103164. doi: 10.3389/fneur.2023.1103164. eCollection 2023.
6
Genetic Study of Early Onset Parkinson's Disease in Cyprus.塞浦路斯早发性帕金森病的遗传学研究。
Int J Mol Sci. 2022 Dec 6;23(23):15369. doi: 10.3390/ijms232315369.
7
Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.早发性帕金森病的年龄界定:国际帕金森病和运动障碍协会早发性帕金森病特别工作组的建议
Mov Disord Clin Pract. 2022 Sep 10;9(7):869-878. doi: 10.1002/mdc3.13523. eCollection 2022 Oct.
8
First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark Study.2019 - 2021年阿联酋帕金森病在阿联酋人和外籍人口中的前两年观察性探索性真实生活临床表型及社会影响研究:EmPark研究
J Pers Med. 2022 Aug 9;12(8):1300. doi: 10.3390/jpm12081300.
9
Inflammation and immune dysfunction in Parkinson disease.帕金森病中的炎症和免疫功能障碍。
Nat Rev Immunol. 2022 Nov;22(11):657-673. doi: 10.1038/s41577-022-00684-6. Epub 2022 Mar 4.
10
Parkinson's in the bone.骨骼中的帕金森病。
Cell Biosci. 2021 Nov 5;11(1):190. doi: 10.1186/s13578-021-00702-5.

本文引用的文献

1
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.杂合型帕金蛋白点突变在对照受试者和帕金森病患者中同样常见。
Ann Neurol. 2007 Jan;61(1):47-54. doi: 10.1002/ana.21039.
2
Genetics of Parkinson's disease and parkinsonism.帕金森病及帕金森综合征的遗传学
Ann Neurol. 2006 Oct;60(4):389-98. doi: 10.1002/ana.21022.
3
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.早发型和晚发型帕金森病中LRRK2突变的频率
Neurology. 2006 Nov 28;67(10):1786-91. doi: 10.1212/01.wnl.0000244345.49809.36. Epub 2006 Oct 18.
4
Phenotypic spectrum of PINK1-associated parkinsonism in 15 mutation carriers from 1 family.来自1个家族的15名突变携带者中与PINK1相关帕金森综合征的表型谱。
Mov Disord. 2007 Jan;22(1):145-7. doi: 10.1002/mds.21059.
5
Clinical features and gene analysis in Korean patients with early-onset Parkinson disease.韩国早发性帕金森病患者的临床特征与基因分析
Arch Neurol. 2006 Aug;63(8):1170-4. doi: 10.1001/archneur.63.8.1170.
6
Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?一个患有帕金森病的德国家庭中纯合子和杂合子PINK1突变的临床谱:单次打击的作用?
Arch Neurol. 2006 Jun;63(6):833-8. doi: 10.1001/archneur.63.6.833.
7
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.帕金森病相关基因parkin杂合突变对家族性帕金森病发病年龄的影响:基因帕金森病(GenePD)研究
Arch Neurol. 2006 Jun;63(6):826-32. doi: 10.1001/archneur.63.6.826.
8
Case-control study of the parkin gene in early-onset Parkinson disease.早发性帕金森病中帕金基因的病例对照研究。
Arch Neurol. 2006 Apr;63(4):548-52. doi: 10.1001/archneur.63.4.548.
9
Implications of genetics on the diagnosis and care of patients with Parkinson disease.遗传学对帕金森病患者诊断与护理的影响。
Arch Neurol. 2006 Mar;63(3):328-34. doi: 10.1001/archneur.63.3.328.
10
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.一个有77名帕金基因突变携带者的大家族中的路易体帕金森病。
Ann Neurol. 2005 Sep;58(3):411-22. doi: 10.1002/ana.20587.